Realta Investment Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Realta Investment Advisors’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$201K	Buy	1,277 +689	+117%	+$109K	0.06%	208
2026 Q2	$93.1K	Hold	588	–	–	0.03%	242
2026 Q1	$75.1K	Hold	588	–	–	0.03%	240
2025 Q4	$71.7K	Hold	588	–	–	0.02%	234
2025 Q3	$58.9K	Buy	588 +74	+14%	+$6.67K	0.02%	232
2025 Q2	$42.6K	Sell	514 -74	-13%	-$5.9K	0.02%	237
2025 Q1	$47.7K	Hold	588	–	–	0.02%	235
2024 Q4	$54.3K	Sell	588 -51	-8%	-$4.94K	0.02%	247
2024 Q3	$63.3K	Sell	639 -3,488	-85%	-$343K	0.03%	232
2024 Q2	$383K	Sell	4,127 -810	-16%	-$72.6K	0.07%	272
2024 Q1	$469K	Sell	4,937 -330	-6%	-$30.6K	0.1%	244
2023 Q4	$470K	Sell	5,267 -840	-14%	-$62.4K	0.11%	227
2023 Q3	$508K	Buy	6,107 +100	+2%	+$7.99K	0.12%	206
2023 Q2	$500K	Sell	6,007 -210	-3%	-$17.6K	0.11%	222
2023 Q1	$474K	Sell	6,217 -2,255	-27%	-$187K	0.12%	213
2022 Q4	$703K	Hold	8,472	–	–	0.17%	139
2022 Q3	$672K	Sell	8,472 -963	-10%	-$81.2K	0.18%	146
2022 Q2	$722K	Buy	9,435 +58	+0.6%	+$4.35K	0.18%	133
2022 Q1	$843K	Buy	9,377 +4,245	+83%	+$392K	0.17%	134
2021 Q4	$575K	Buy	5,132 +230	+5%	+$27.7K	0.13%	190
2021 Q3	$616K	Buy	4,902 +50	+1%	+$6.44K	0.15%	176
2021 Q2	$657K	Sell	4,852 -40	-0.8%	-$5.26K	0.16%	164
2021 Q1	$664K	Buy	4,892 +21	+0.4%	+$3.14K	0.17%	151
2020 Q4	$686K	Buy	4,871 +6	+0.1%	+$769	0.19%	121
2020 Q3	$542K	Sell	4,865 -135	-3%	-$15.1K	0.18%	144
2020 Q2	$560K	Buy	5,000 +275	+6%	+$27.1K	0.18%	139
2020 Q1	$366K	Buy	4,725 +641	+16%	+$56.8K	0.16%	177
2019 Q4	$383K	Buy	4,084 +373	+10%	+$32.3K	0.1%	224
2019 Q3	$286K	Buy	3,711 +470	+15%	+$39.1K	0.08%	265
2019 Q2	$286K	Buy	3,241 +1,229	+61%	+$105K	0.08%	265
2019 Q1	$185K	Buy	+2,012	New	+$171K	0.08%	283

Other funds holding XBI

Annex Advisory Services Brookfield, Wisconsin $6.11B AUM 13.75% 1-Year Est. Return

MIRAE ASSET SECURITIES (USA) INC. New York $3.57B AUM 26.78% 1-Year Est. Return

SGH

Sivik Global Healthcare Greenwich, Connecticut $175M AUM 28.78% 1-Year Est. Return

EWM

Edge Wealth Management New York $666M AUM 17.64% 1-Year Est. Return

LHWM

Lake Hills Wealth Management Austin, Texas $218M AUM 31.66% 1-Year Est. Return

AIC

Ayalon Insurance Company Ramat Gan, Israel $1.2B AUM 25.57% 1-Year Est. Return

MWA

MFA Wealth Advisors Pittsburgh, Pennsylvania $589M AUM 19.71% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Fiduciary Alliance Greenville, South Carolina $1.33B AUM 15.58% 1-Year Est. Return

MAM

Marotta Asset Management Charlottesville, Virginia $589M AUM 14.57% 1-Year Est. Return

Realta Investment Advisors's XBI Position: Q3 2026 in Review

Realta Investment Advisors increased its State Street SPDR S&P Biotech ETF (XBI) stake by 117% in Q3 2026, buying an estimated $109K and bringing the position to 1,277 shares worth $201K. The position accounts for 0.06% of the portfolio, ranked #208.

Realta Investment Advisors first reported a position in XBI in Q1 2019 and has held it in 31 quarters since. The position peaked at $843K in Q1 2022. 120 funds tracked by Wall St. Rank hold XBI as of Q3 2026.

Realta Investment Advisors held 1,277 shares of State Street SPDR S&P Biotech ETF worth $201K as of Q3 2026.
Realta Investment Advisors bought 689 State Street SPDR S&P Biotech ETF shares in Q3 2026, an estimated $109K.
State Street SPDR S&P Biotech ETF made up 0.06% of Realta Investment Advisors's portfolio in Q3 2026, its #208 holding.
Realta Investment Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q1 2019 and has held it in 31 quarters since.
Realta Investment Advisors's State Street SPDR S&P Biotech ETF position peaked at $843K in Q1 2022.
120 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.

Based on Realta Investment Advisors's 13F filing for Q3 2026, filed 14 Oct 2026.